Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours

European Journal of Nuclear Medicine

Volumn 23, Issue 8, 1996, Pages 947-952

  Ho, S ^a   Lau, W Y ^a   Leung, T W T ^a   Chan, M ^a   Ngar, Y K ^a   Johnson, P J ^a   Li, A K C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatic tumours; Partition model; Radiation doses; Yttrium 90

Indexed keywords

MACROSALB TC 99M; RADIOACTIVE MICROSPHERE; YTTRIUM 90;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; LAPAROTOMY; LIVER TUMOR; MALE; MATHEMATICAL MODEL; RADIATION DOSE;

EID: 0029737746     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01084369     Document Type: Article

References (29)

1. Ariel IM. Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres). Ann Surg 1965; 162: 267-278.
2. Ariel IM, Pack GT. Treatment of inoperable cancer by intraarterial radioactive isotopes and chemotherapy. Cancer 1967; 20: 793-804.
3. Grady ED. Internal radiation therapy of hepatic cancer. Dis Colon Rectum 1979; 22: 371-375.
4. Mantravadi RVP, Spigos DG, Tan WS, Felix EL. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 1982; 142: 783-786.
5. Ariel IM, Padula G. Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes. J Surg Oncol 1982; 20: 151-156.
6. Herba MJ, Illescase FF, Thirlwell MP etal. Hepatic malignancies: improved treatment with intraarterial Y-90. Radiology 1988; 169: 311-314.
7. Blanchard RJW, Morrow IM, Sutherland JB. Treatment of liver tumours with yttrium-90 microspheres alone. J Can Assoc Radiol 1989; 40: 206-210.
8. Houle S, Yip TCK, Shepherd FA etal. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiology 1989; 172: 857-860.
9. Shepherd FA. Rostein LE, Houle S, Yip TCK, Paul K, Sniderman KW. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 1992; 70: 2250-2254.
10. Andrews JC, Walker SC, Ackermann RJ, Cotton LA, Ensminger WD, Shapiro B. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminity results and clinical follow-up. J Nucl Med 1994; 35: 1637-1644.
11. Synder WS, Ford MR, Warner GG, Watson SB. "S" absorbed dose per unit cumulative activity for selected radionuclides and organs NM/MIRD. Pamphlet No. 11. New York: Society of Nuclear Medicine, 1975.
12. Zeissman HA, Thrall JH, Yang PJ etal. Hepatic arterial perfusion scintigraphy with Tc-99m MAA. Radiology 1984; 152: 167-172.
13. Goldberg JA, Bradnam MS. Kerr DJ etal. Arteriovenous shunting of microspheres in patients with colorectal liver metastases: error in assessment due to free pertechnetate, and the effect of angiotensin II. Nucl Med Commun 1987; 8: 1033-1046.
14. Lau WY, Leung TWT, Ho S etal. Diagnostic pharmacoscintigraphy with technetium-99m macroaggregated albumin in the prediction of tumour to normal uptake ratio during therapy of inoperable hepatocellular carcinoma with yttrium-90 microspheres. Br J Radiol 1994; 67: 136-139.
15. Leung WT, Lau WY, Ho S etal. Measuring lung shunting in hepatocellular carcinoma with intra-arterial technetium-99m macroaggregated albumin. J Nucl Med 1994; 35: 70-73.
16. Lau WY, Leung WT, Ho S etal. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 1994; 70: 994-999.
17. 90Y in liver tissue. Nucl Med Biol 1989; 16: 495-498.
18. Burton MA, Gray BN, Klemp PF, Kelleher DK, Hardy N. Selective internal radiation therapy: distribution of radiation in the liver. Eur J Cancer Clin Oncol 1989; 25: 1487-1491.
19. Burton MA, Gray BN, Kelleher DK, Klemp PF. Selective internal radiation therapy: validation of intraoperative dosimetry. Radiology 1990; 175: 253-255.
20. Gray BN, Burton MA, Kelleher D, Klemp P, Matz L. Tolerance of the liver to the effects of yttrium-90 radiation. Int J Radiat Oncol Biol Phys 1990; 18: 619-623.
21. Weber DA, Eekeman KF, Dillman LT, Ryman JC. MIRD: radionuclide data and decay schemes. New York: Society of Nuclear Medicine; 1989: 159.
22. Shen S, DeNardo GL, DeNardo SJ. Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter. Med Phys 1994; 21: 1409-1417.
23. Lau WY, Li AKC. Therapeutic aspects of radioisotopes in hepatobiliary malignancy. Br J Surg 1992; 79: 711.
24. Siegel JA, Handy DM, Kopher KA, Zeiger LS, Order SE. Therapeutic beta irradiating isotopes in bony metastases: a technique for bremsstrahlung imaging and quantitation. Antibody Immunoconj Radiopharm 1992; 5: 237-248.
25. Order SE, Siegel JA, Lusting RA etal. Infusional brachytherapy in the treatment of nonresectable pancreatic cancer: a new radiation modality (preliminary report of the phase I study). Antibody Immunoconj Radiopharm 1994; 7: 11-27.
26. Siegel JA, Zeiger LS, Order SE, Wallner PE. Quantitative bremsstrahlung single photon emission computed tomographic image use for volume, activity, and absorbed dose calculation. Int J Radiat Oncol Biol Phys 1995; 31: 953-958.
27. Feinendegen LE. Microdosimetric considerations of hepatic radioembolization [editorial]. J Nucl Med 1994; 35: 1644-1645.
28. Fox RA, Klemp PFB, Egan G, Mina LL, Burton MA, Gray BN. Dose distribution following selective internal radiation therapy, Int J Radiat Oncol Biol Phys 1991; 21: 463-467.
29. Roberson, Ten Haken RK, Mcshan DL, McKeever PE, Ensminger WD. Three dimensional tumour dosimetry for hepatic yttrium-90-microsphere therapy. J Nucl Med 1992; 33: 735-738.